Straumann Holding AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH1175448666
CHF
95.76
0.18 (0.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Straumann Holding AG stock-summary
stock-summary
Straumann Holding AG
Pharmaceuticals & Biotechnology
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
Company Coordinates stock-summary
Company Details
Peter Merian-Weg 12 , BASEL None : 4002
stock-summary
Tel: 41 61 9651111
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 4 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Gilbert Achermann
Non-Executive Chairman of the Board
Dr. Thomas Straumann
Non-Executive Vice Chairman of the Board of Directors
Ms. Monique Bourquin
Non-Executive Director
Mr. Juan-Jose Gonzalez
Non-Executive Director
Mr. Ulrich Looser
Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 14,670 Million ()

stock-summary
P/E

56.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.03%

stock-summary
Debt Equity

-0.05

stock-summary
Return on Equity

12.03%

stock-summary
Price to Book

7.13